GB-6
GB-6 is a short linear peptide that targets the gastrin releasing peptide receptor (GRPR). GRPR is overexpressed in pancreatic cancer. Based on the tumor selectivity and tumor-specific accumulation properties of GB-6, GB-6 labeled with near infrared (NIR) fluorescent dyes or radionuclide netium-99m (99mTc) can be used as a high-contrast imaging probe. GB-6 has excellent in vivo stability, with tumor to pancreatic and intestinal fluorescence signal ratios of 5.2 and 6.3, respectively, in SW199 0 subcutaneous xenograft models. GB-6 can rapidly target tumors and accurately delineate tumor boundaries, which has broad application prospects.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2413262-74-3
- Formel: C32H45N11O8
- Molecular Weight:711.77
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Radionuclide-Drug Conjugates (RDCs) Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
RDC Peptide |
Chemical Information
-
CAS. Nr. 2413262-74-3
-
Molecular Weight 711.77
-
Formel C32H45N11O8
-
Sequence
Gln-{Htp}-{β-Ala}-{Nva}-Gly-His-NH2
-
Sequence Shortening
Q-{Htp}-{β-Ala}-{Nva}-GH-NH2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)